Series a non-voting convertible preferred stock, 0.0001 par value 2,104 shares authorized and 2,103.1494 shares issued and outstanding at september 30, 2025 and 2,270 shares authorized and 2,213.8044 shares issued and outstanding at december 31, 2024
Common stock, 0.0001 par value 43,000,000 shares authorized 33,409,271 and 33,401,553 shares issued and outstanding at march 31, 2026, respectively and 29,751,234 and 29,743,516 shares issued and outstanding at december 31, 2025, respectively
3,340
2,974
229
191
Additional paid-in capital
195,703,020
183,856,376
73,158,686
71,001,615
Accumulated deficit
-113,062,930
-108,076,316
-104,295,867
-88,551,251
Accumulated other comprehensive loss
-1,720,950
-587,039
-1,636,135
-267,289
Stockholders' equity before treasury stock
80,922,480
75,195,995
7,557,280
7,177,727
Less treasury stock, 7,718 shares of common stock at cost
299,128
299,128
299,128
299,128
Total stockholders' equity
80,623,352
74,896,867
7,258,152
6,878,599
Total liabilities, series a non-voting convertible preferred stock and stockholders' equity
95,207,871
90,171,237
91,992,613
96,692,527
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.